Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Devices

DXCM:US

62.3400 USD 0.3600 0.58%

As of 20:10:00 ET on 03/31/2015.

Snapshot for DexCom Inc (DXCM)

Open: 61.6900 Day's Range: 61.4000 - 62.8600 Volume: 817,810
Previous Close: 61.9800 52wk Range: 28.0900 - 64.6400 1-Yr Rtn: +50.98%

Stock Chart for DXCM

No chart data available.
  • DXCM:US 62.4100
  • 1D
  • 1M
  • 1Y
61.9800
Interactive DXCM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DXCM

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 5,667.2727
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3389
Est. EPS (USD) (12/2015) 0.0110
Est. PEG Ratio 174.3776
Market Cap (M USD) 4,832.26
Shares Outstanding (M) 77.51
30 Day Average Volume 718,715
Price/Book (mrq) 34.3715
Price/Sale (ttm) 18.1511
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/01/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DXCM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DXCM

DexCom Inc. is a medical device company focused on the design and development of continuous glucose monitoring systems for people with diabetes. The Company has developed a small implantable device that continuously measures glucose levels in subcutaneous tissue just under the skin, and a small external receiver to which the sensor transmits glucose levels at specified intervals.

Terrance H Gregg "Terry"ChairmanKevin R SayerPresident/CEO
Jorge A ValdesChief Technology OfficerSteven R PacelliExec VP:Strategy
More Company Profile & Key Executives for DXCM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil